Synthetic torpor has potential to redefine medicine
Hong Chen, a biomedical engineer at WashU, shares the potential for using synthetic torpor technology to develop new treatments for a range of illnesses and injuries.
Career Catalysts: WashU stipends fund internships, fuel professional growth
Career Catalysts is a new series by WashU interns, about WashU interns. In this installment, see how Fiona Sun, a McKelvey School of Engineering student, is working with Equine Smartbit to develop a sort of smartwatch for horses at Fairmount Park.
Brown School faculty win $1.4M grant to study economic mobility, wealth gaps
Two Brown School faculty members have been awarded a combined $1.4 million in grants from the Ewing Marion Kauffman Foundation to support research focused on improving economic mobility and reducing wealth disparities.
AI-based brain-mapping software receives FDA market authorization
The FDA has given market authorization to a WashU startup’s technology that quickly and accurately maps the sensitive areas in patients’ brains to help neurosurgeons plan safe and effective surgeries.
New hydrogel treatments turn water waste into fertilizer
Environmental engineers at WashU have developed hydrogels to transform wastewater nutrients into useful feedstocks and fertilizers.
Mitra receives innovation award
Robi Mitra at WashU Medicine has received the Chancellor’s Award for Innovation and Entrepreneurship. In addition, in 2024 WashU jumped 11 places to No. 26 on the National Academy of Inventors list of the top 100 U.S. universities granted U.S. utility patents.
First WashU Venture Network Follow-on Investments awarded
Three St. Louis startups won the first-ever WashU Venture Network Follow-on Investments April 17 during a special Skandalaris Center event.
WashU rises in global patent ranking
WashU rises in the National Academy of Inventors’ annual global ranking of patent awards.
What Walgreens’ $10 billion private equity deal means for consumers, pharmacy industry
After years of financial turmoil, Walgreens recently announced that it has reached a $10 billion buyout deal with private-equity firm Sycamore — a move that likely will have wide-ranging consequences for how consumers access health care and health-care products, according to Olin Business School experts Patrick Aguilar and Peter Boumgarden.
Olin launches new Business of Health initiative
WashU Olin Business School recently launched a new health initiative that envisions Olin as the premier institution for the business of health and an engine for innovation at WashU.
Older Stories